IL6 and Crohn disease: They have shown that AdMSCs had an anti-inflammatory effect by decreasing TNFa, IL6, and other proinflammatory cytokines, as well as increasing the expression of IL-10, thus downregulating the Th1 mediated inflammatory response, which is similar both in DSS colitis and Crohn’s disease [58].